Table 2.
Comparison of measured plasma OPN and VEGF levels with clinical parameters in patients with MM.
| Durie-Salmon stage | P value | Bone lesions | P value | Anemia | P value | Renal dysfunction | P value | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I, II | III | Yes | No | Yes | No | Yes | No | |||||
| OPN (ng/mL) | ||||||||||||
| Median | 5.65 | 8.9 | 0.05 | 7.4 | 2.8 | 0.03 | 7.6 | 6.6 | 0.29 | 12.6 | 7.05 | 0.13 |
| Range | 0.3–14.6 | 2.2–26.5 | 3.3–26.5 | 0.3–12.9 | 0.3–26.5 | 2.3–12.9 | 3.7–26.5 | 0.3–22.2 | ||||
| VEGF (pg/mL) | ||||||||||||
| Median | 35.9 | 60.15 | 0.04 | 48.1 | 55.75 | 0.79 | 57.4 | 47 | 0.43 | 46.9 | 59 | 0.51 |
| Range | 5.3–111.7 | 20.3–178.9 | 5.3–178.9 | 22.6–111.7 | 5.3–178.9 | 29.2–69.2 | 20.3–148.9 | 5.3–178.9 | ||||